Cancer of the Prostate: Molecular Genetics
217
Reichardt, J.K., Makridakis, N., Henderson, B.E.,
et al. (1995) Genetic variability of the human
SRD5A2 gene: implications for prostate cancer
risk,
Cancer Res.
55
, 3973–3975.
Richmond, P.J.,
Karayiannakis, A.J.,
Naga-
fuchi, A., et al. (1997) Aberrant Ecadherin and
α
-catenin expression in prostate cancer: cor-
relation with patient survival,
Cancer Res.
57
,
3189–3193.
Rokman, A.,
Ikonen, T.,
Seppala, E.H.,
Nup-
ponen, N., Autio, V., Mononen, N., Bailey-
Wilson, J., Trent, J., Carpten, J., Matikainen,
M.P., Koivisto, P.A., Tammela, T.L., Kallion-
iemi, O.P., Schleutker, J. (2002) Germline al-
terations of the RNASEL gene, a candidate
HPC1 gene at 1q25, in patients and families
with prostate cancer,
Am.J.Hum.Genet.
70
(5),
1299–1304.
Rosini,
P.,
Bonaccorsi,
L.,
Baldi,
E.,
Chiasserini, C.,
Forti, G.,
De
Chiara, G.,
Lucibello, M.,
Mongiat,
M.,
Iozzo,
R.V.,
Garaci, E., Cozzolino, F., Torcia, M.G. (2002)
Androgen receptor expression induces FGF2,
FGF-binding protein production, and FGF2
release in prostate carcinoma cells: role of
FGF2 in growth, survival,
and androgen
receptor
down-modulation,
Prostate
53
(4),
310–321.
Ross, J.S., Sheehan, C., Hayner-Buchan, A.M.,
et al. (1997) HER-2/neu gene ampli±cation
status in prostate cancer by fluorescence in
situ hybridization,
Hum. Pathol.
28
, 827–833.
R
u
i
j
t
e
r
,E
.
,v
a
nd
eK
a
a
,C
.
,M
i
l
l
e
r
,G
.
,e
t
a
l
.
(1999) Molecular genetics and epidemiology
of prostate cancer,
Endocr. Rev.
20
, 22–45.
Ruijter, E.T., Miller, G.J., Aalders, T.W., et al.,
Biomed-II MPC Study Group. (1997) Rapid
microwave
stimulated
±xation
of
entire
prostatectomy
specimens,
J.
Pathol.
183
,
369–375.
Sakr, W.A.,
Macoska, J.A.,
Benson, P.,
et al.
(1994)
Allelic
loss
in
locally
metastatic,
multisampled prostate cancer,
Cancer Res.
54
,
3273–3277.
Santourlidis, S., Florl, A., Ackermann, R., et al.
(1999)
High
frequency
of
alterations
in
DNA methylation in adenocarcinoma of the
prostate,
Prostate
39
, 166–174.
Schaid, D.J.,
McDonnell, S.K.,
Blute, M.L.,
Thibodeau, S.N. (1998) Evidence of autosomal
dominant inheritance of prostate cancer,
Am.
J. Hum. Genet.
62
, 1425–1438.
Schalken, J.A., Smit, F., Bringuier, P.P., et al.
(1995) The role of E-cadherin mutations in
bladder and prostate cancer: is E-cadherin a
classical tumor suppressor gene?
Urol. Res.
23
,
P57.
Serrano, M., Hannon, G.J., Beach, D. (1993) A
new regulatory motif in cell-cycle control
causing speci±c inhibition of cyclin D/CDK4,
Nature
366
, 704–707.
Smith, J.R., Freije, D., Carpten, J.D., et al. (1996)
Major susceptibility locus for prostate cancer
on chromosome 1 suggested by genome-wide
search,
Science
274
, 1371–1374.
Smith, J.R.,
Freije, D.,
Carpten, J.D.,
Gron-
berg,H
.
,Xu
,J
.
,Isaacs
,S
.D
.
,Brownstein
,M
.J
.
,
Bova, G.S., Guo, H., Bujnovszky, P., Nusskern,
D.R.,
Damber, J.E.,
Bergh, A.,
Emanuels-
son, M., Kallioniemi, O.P., Walker-Daniels, J.,
Bailey-Wilson, J.E., Beaty, T.H., Meyers, D.A.,
Walsh, P.C., Collins, F.S., Trent, J.M., Isaacs,
W.B. (1996) Major susceptibility locus for
prostate cancer on chromosome 1 suggested
by a genome-wide search,
Science
274
(5291),
1371–1374.
Sommerfeld, H.-J., Meeker, A.K., Piatyszek,
M.A.,
et al.
(1996)
Telomerase
activity:
a
prevalent
marker
of
malignant
human
prostate tissue,
Cancer Res.
56
, 218–222.
Stanford, J.L., Just, J.J., Gibbs, M., et al. (1997)
Polymorphic repeats in the androgen receptor
gene: molecular markers of prostate cancer
risk,
Cancer Res.
57
, 1194–1198.
Stapleton, A.M.F.,
Timme, T.L.,
Gousse, E.A.,
et al. (1997) Primary human prostate cancer
cells harboring p53 mutations are clonally
expanded in metastases,
Clin. Cancer Res.
3
,
1389–1397.
Steiner, M.S. (1995) Review of peptide growth
factors
in
benign
prostatic
hyperplasia
and
urological
malignancy,
J. Urol.
153
,
1085–1096.
Suzuki,
H.,
Freije,
D.,
Nusskern,
D.R.,
et al.
(1998)
Interfocal
heterogeneity
of
PTEN/MMAC1 gene alterations in multiple
metastatic prostate cancer tissues,
Cancer Res.
58
, 204–209.
Suzuki, H., Komiya, A., Aida, S., et al. (1995)
Microsatellite instability and other molecular
abnormalities in human prostate cancer,
Jpn.
J. Cancer Res.
86
, 956–961.
Suzuki, H., Komiya, A., Aida, S., et al. (1995)
Microsatellite instability and other molecular
abnormalities in human prostate cancer,
Jpn.
J. Cancer Res.
86
, 956–961.
Suzuki, H., Komiya, A., Emi, M., et al. (1996)
Three distinct commonly deleted regions of
previous page 891 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 893 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off